According to the Norwegian authorities, the US pharmaceutical giant Pfizer has warned of impending delivery cuts in the vaccine against the corona virus, which was developed together with the Mainz-based company Biontech. “ The temporary cut will affect all European countries,” said the state health institute in Oslo on Friday. The cuts would take place “from next week”, and Pfizer wants to improve its production capacities during this time.
Pfizer wants to improve production capacities
“It is currently not clear exactly how long it will take before Pfizer will reach its maximum production capacity, which is expected to increase from 1.3 billion to two billion doses annually,” the statement said. Information about the delivery quantities for the whole of Europe was not given, only for Norway: Accordingly, only 36,075 vaccine doses are expected for the Scandinavian country in the coming week, previously it was 43,875. This corresponds to a minus of almost 18 percent.
The vaccine from Biontech and Pfizer was the first vaccine against the coronavirus to be approved in the European Union (EU). It is already widely used. As a second vaccine, the drug from the US manufacturer Moderna has now also received Europe-wide approval; the corona vaccine from the British-Swedish manufacturer AstraZeneca is currently being tested by the European Medicines Agency (EMA).
>> Current news about the corona crisis